Self-help Guided by Lay Providers for Anxiety in Older Adults
Generalized Anxiety Disorder in Older Adults : Efficacy of a Self-help Treatment Guided by Trained Lay Providers
1 other identifier
interventional
150
1 country
3
Brief Summary
Few older adults receive treatment for Generalized Anxiety Disorder (GAD) despite a high prevalence in this population and significant associated health care costs. Although older adults generally prefer psychotherapy to medication for help with anxiety, face-to-face psychotherapy is difficult to access for many of them. Psychological guided self-help (GSH), which patients use by themselves at home under the supervision of a licensed mental health provider (e.g., psychologist), has been shown to be effective. However, the capacity of our health care system to respond adequately to the mental health needs of seniors has been questioned and cost-effective solutions are required. Because the therapist's role in GSH is limited to supporting the patient, it is conceivable that this role could be assumed by trained and supervised lay providers (LP) instead of licensed providers. If this approach is effective, it could help provide many older adults with much needed mental health treatment at a lower cost. The main objective of this project is to evaluate the effectiveness of GSH guided by LP for GAD in older adults. Participants will be assigned randomly to an experimental group, which will receive treatment immediately, or to a control group whose treatment will be delayed. Data will be obtained through clinician evaluations and self-assessment questionnaires. They will include socio-demographic characteristics, symptoms of GAD, variables related to anxiety, such as depression and sleep difficulties, and participants' perception of treatment. For the experimental group, data collection will take place at four different times: before treatment begins, after treatment ends, and at 6 and 12 months after the end of treatment. Control group participants will be assessed on three occasions: before and after the waiting period and after receiving treatment. The efficacy of GSH will be established by comparing the change in the two groups on the main variables. We will also identify the characteristics of patients associated with improvement during treatment and document their perception of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2018
CompletedFirst Posted
Study publicly available on registry
December 7, 2018
CompletedStudy Start
First participant enrolled
March 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 24, 2023
CompletedOctober 4, 2023
October 1, 2023
4 years
November 21, 2018
October 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Penn State Worry Questionnaire
16 items rated on a scale ranging from 1 to 5. A higher total score indicates a greater tendency to worry.
Baseline, post treatment (15 weeks), 6 months and 12 months follow-up.
Change in GAD-7
7 items answered on a scale ranging from 0 to 3. A higher total score suggests greater severity.
Baseline, post treatment (15 weeks), 6 months and 12 months follow-up.
Secondary Outcomes (10)
Change in Intolerance to Uncertainty Inventory
Baseline, post treatment (15 weeks), 6 months and 12 months follow-up.
Change in Negative Problem Orientation Questionnaire
Baseline, post treatment (15 weeks), 6 months and 12 months follow-up.
Change in Cognitive Avoidance Questionnaire
Baseline, post treatment (15 weeks), 6 months and 12 months follow-up.
Change in Why Worry Questionnaire
Baseline, post treatment (15 weeks), 6 months and 12 months follow-up.
Change in Geriatric Anxiety Inventory
Baseline, post treatment (15 weeks), 6 months and 12 months follow-up.
- +5 more secondary outcomes
Other Outcomes (3)
Evaluation of treatment by participants
Post treatment (15 weeks)
Questionnaire of behavioral manifestations linked to anxiety
Baseline, post treatment (15 weeks), 6 months and 12 months follow-up.
Nine items relating to COVID-19
Baseline, post treatment (15 weeks), 6 months and 12 months follow-up.
Study Arms (2)
Self-help guided by a lay provider
EXPERIMENTALWaiting list where participants wait for delayed treatment
OTHERInterventions
Self-help based on the principles of cognitive-behavioral therapy and guided by a lay provider. Treatment lasts 15 weeks, is based on a participant's manual, and consists of relaxation, differentiation of the main types of worries, learning to tolerate uncertainty, questioning false beliefs about worries, problem solving, cognitive exposure, and planning pleasant activities. Weekly telephone sessions with the lay provider serve to provide support.
Participants have a 15-week wait period during which they receive a 15-minute telephone call from the local professional research assistant on three occasions separated by four-week intervals. The purpose of these calls is to encourage the participant to persevere until the start of treatment and to identify potential negative effects that could be associated with the waiting period. Participants receive self-help guided by a lay provider after the waiting period.
Eligibility Criteria
You may qualify if:
- years of age or older
- meet at least criteria for subthreshold GAD at screening based on items of the Worry and Anxiety Questionnaire
- meet DSM-5 criteria for primary threshold or subthreshold GAD
- be able to read and speak French and to use the telephone without difficulty
- if an anxiety medication is used, commit to maintaining the type of medication or dose during eight weeks prior to treatment and during the protocol.
You may not qualify if:
- a disabling physical disorder that is not adequately controlled (e.g., acute heart disease, recent stroke)
- the presence of a substance use disorder
- presenting a bipolar disorder or symptoms of a psychotic disorder
- having significant cognitive impairment (score of less than 22 on the Telephone version of the Mini-Mental State Examination)
- currently receiving or having received psychotherapy for anxiety over the last six months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
- Canadian Institutes of Health Research (CIHR)collaborator
- CIUSSS du Centre-Sud-de-l'Île-Montréalcollaborator
- Estrie University Integrated Health and Social Services Center - University Hospital of Sherbrookecollaborator
- Integrated University Health and Social Services Center of the Capitale-Nationalecollaborator
Study Sites (3)
Centre de recherche de l'Institut universitaire de gériatrie de Montréal
Montreal, Quebec, H3W 1W4, Canada
École de psychologie, Université Laval
Québec, Quebec, G1V 0A6, Canada
Département de psychologie, Université de Sherbrooke
Sherbrooke, Quebec, J1K 2R1, Canada
Related Publications (1)
Landreville P, Gosselin P, Grenier S, Carmichael PH. Self-help guided by trained lay providers for generalized anxiety disorder in older adults: study protocol for a randomized controlled trial. BMC Geriatr. 2021 May 22;21(1):324. doi: 10.1186/s12877-021-02221-x.
PMID: 34022795DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full professor
Study Record Dates
First Submitted
November 21, 2018
First Posted
December 7, 2018
Study Start
March 11, 2019
Primary Completion
February 24, 2023
Study Completion
February 24, 2023
Last Updated
October 4, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share